Published in J Altern Complement Med on June 01, 2008
Complementary and alternative medicine for the treatment of multiple sclerosis. Expert Rev Clin Immunol (2010) 0.89
A multimodal intervention for patients with secondary progressive multiple sclerosis: feasibility and effect on fatigue. J Altern Complement Med (2014) 0.76
An inventory for measuring depression. Arch Gen Psychiatry (1961) 84.61
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology (1983) 40.64
New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol (1983) 26.67
Multiple sclerosis. N Engl J Med (2000) 12.69
The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res (1995) 9.99
Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills (1977) 6.58
Interferons in relapsing remitting multiple sclerosis: a systematic review. Lancet (2003) 4.89
Immunological aspects of demyelinating diseases. Annu Rev Immunol (1992) 4.39
The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler (1999) 3.71
Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis (1994) 3.59
The left frontal lobe of man and the suppression of habitual responses in verbal categorical behaviour. Neuropsychologia (1974) 2.89
Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population. Med Care (2000) 1.84
The multiple sclerosis functional composite: a new clinical outcome measure for multiple sderosis trials. Mult Scler (2002) 1.71
Immunologic mechanisms and therapy in multiple sclerosis. Immunol Rev (1995) 1.33
Use of unconventional therapies by individuals with multiple sclerosis. Clin Rehabil (2003) 1.27
Recent developments in the assessment of quality of life in multiple sclerosis (MS). Mult Scler (1999) 1.23
Predictors of alternative medicine use by multiple sclerosis patients. Mult Scler (2003) 1.14
Intraindividual change in SF-36 in ambulatory clinic primary care patients predicted mortality and hospitalizations. J Clin Epidemiol (2004) 0.93
Utilization of unconventional treatments by persons with MS: is it alternative or complementary? Neurology (1999) 0.92
Complementary and alternative medicine in multiple sclerosis: survey of licensed naturopaths. J Altern Complement Med (2004) 0.87
Complementary and alternative therapy use in persons with multiple sclerosis. Rehabil Nurs (2003) 0.87
The use of complementary and alternative therapies by people with multiple sclerosis. Chronic Dis Can (2003) 0.83
Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA (2003) 2.69
Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res (2005) 2.39
Survey of physician attitudes and practices related to pediatric obesity. Clin Pediatr (Phila) (2003) 2.16
A pilot whole systems clinical trial of traditional Chinese medicine and naturopathic medicine for the treatment of temporomandibular disorders. J Altern Complement Med (2008) 2.10
"Undiagnosing" multiple sclerosis: the challenge of misdiagnosis in MS. Neurology (2012) 1.94
Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol (2007) 1.86
Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Proc Natl Acad Sci U S A (2007) 1.76
Assessment of the quality of colonoscopy reports: results from a multicenter consortium. Gastrointest Endosc (2009) 1.64
Algorithm for complementary and alternative medicine practice and research in type 2 diabetes. J Altern Complement Med (2007) 1.64
Serious complications within 30 days of screening and surveillance colonoscopy are uncommon. Clin Gastroenterol Hepatol (2009) 1.64
Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology. Neurology (2014) 1.54
Imbalance in multiple sclerosis: a result of slowed spinal somatosensory conduction. Somatosens Mot Res (2008) 1.42
Echinacea purpurea for prevention of upper respiratory tract infections in children. J Altern Complement Med (2005) 1.40
Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis. Curr Neurol Neurosci Rep (2009) 1.37
Centella asiatica accelerates nerve regeneration upon oral administration and contains multiple active fractions increasing neurite elongation in-vitro. J Pharm Pharmacol (2005) 1.33
Mind-body interventions: applications in neurology. Neurology (2008) 1.30
Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis. J Neuroimmunol (2009) 1.17
Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors. Mult Scler (2011) 1.16
High-dose probiotics for the treatment of active pouchitis. Dis Colon Rectum (2007) 1.12
Characterizing a practice-based research network: Oregon Rural Practice-Based Research Network (ORPRN) survey tools. J Am Board Fam Med (2007) 1.10
Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators. Eur Heart J (2009) 1.10
Incidence of fecal incontinence after childbirth. Obstet Gynecol (2007) 1.07
Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time: no. Mult Scler (2012) 1.06
Salivary cortisol awakening response in mild Alzheimer disease, caregivers, and noncaregivers. Alzheimer Dis Assoc Disord (2008) 1.05
Attachment and quality of life in patients with inflammatory bowel disease. Int J Colorectal Dis (2014) 1.04
Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures. Epilepsia (2003) 1.04
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects. Eur J Immunol (2013) 1.04
Falls requiring medical attention among veterans with multiple sclerosis: a cohort study. J Rehabil Res Dev (2011) 1.02
Activation of the mitochondrial permeability transition pore modulates Ca2+ responses to physiological stimuli in adult neurons. Eur J Neurosci (2011) 1.02
Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management. CNS Drugs (2002) 1.01
The radiologically isolated syndrome: look (again) before you treat. Curr Neurol Neurosci Rep (2011) 1.01
Discrimination of healthy and neoplastic human colon tissues by ex vivo HR-MAS NMR spectroscopy and chemometric analyses. J Proteome Res (2009) 1.01
Patterns of dietary supplement usage in demographically diverse older people. Altern Ther Health Med (2005) 1.01
Influence of health insurance coverage on breast, cervical, and colorectal cancer screening in rural primary care settings. Cancer (2012) 1.00
Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia (2002) 0.99
Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol (2005) 0.99
Correlations of Perceived Deficits Questionnaire of Multiple Sclerosis Quality of Life Inventory with Beck Depression Inventory and neuropsychological tests. J Rehabil Res Dev (2006) 0.98
Ascorbic acid and rates of cognitive decline in Alzheimer's disease. J Alzheimers Dis (2009) 0.98
Immunotherapy and multiple sclerosis: The devil is in the details. Neurology (2010) 0.98
Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol (2006) 0.98
Performance and return-to-sport after ACL reconstruction in NFL quarterbacks. Orthopedics (2014) 0.98
Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS. Endocr Metab Immune Disord Drug Targets (2008) 0.96
Mind-body practices: an alternative, drug-free treatment for smoking cessation? A systematic review of the literature. Drug Alcohol Depend (2013) 0.96
Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients. Mult Scler (2013) 0.95
Urinary exosomal Wilms' tumor-1 as a potential biomarker for podocyte injury. Am J Physiol Renal Physiol (2013) 0.95
Oxidative stress inhibits axonal transport: implications for neurodegenerative diseases. Mol Neurodegener (2012) 0.94
Disability progression in a clinical trial of relapsing-remitting multiple sclerosis: eight-year follow-up. Arch Neurol (2010) 0.94
Reliability and validity of food frequency questionnaire and nutrient biomarkers in elders with and without mild cognitive impairment. Alzheimer Dis Assoc Disord (2011) 0.93
Burden of illness in Italian patients with gastro-oesophageal reflux disease. Curr Med Res Opin (2005) 0.93
The rural older adult memory (ROAM) study: a practice-based intervention to improve dementia screening and diagnosis. J Am Board Fam Med (2010) 0.93
A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease. J Alzheimers Dis (2014) 0.91
Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis. Immunology (2007) 0.91
Patient-reported experiences with first-time naturopathic care for type 2 diabetes. PLoS One (2012) 0.91
Genetic inactivation of the p66 isoform of ShcA is neuroprotective in a murine model of multiple sclerosis. Eur J Neurosci (2012) 0.91
Survival in HIV-1-positve adults practicing psychological or spiritual activities for one year. Altern Ther Health Med (2007) 0.91
Comparisons of plasma/serum micronutrients between Okinawan and Oregonian elders: a pilot study. J Gerontol A Biol Sci Med Sci (2010) 0.91
Assessing sleep architecture in dementia caregivers at home using an ambulatory polysomnographic system. J Geriatr Psychiatry Neurol (2011) 0.91
Epitope spreading is not required for relapses in experimental autoimmune encephalomyelitis. J Immunol (2003) 0.90
Lipoic acid decreases inflammation and confers neuroprotection in experimental autoimmune optic neuritis. J Neuroimmunol (2011) 0.90
Fingolimod and multiple sclerosis: four cautionary tales. Neurology (2012) 0.90
Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: effect of rituximab. J Transplant (2011) 0.90
Complementary and alternative medicine for the treatment of multiple sclerosis. Expert Rev Clin Immunol (2010) 0.89
Clinical trial of extended-release felodipine in pediatric essential hypertension. Pediatr Nephrol (2003) 0.89
Urease-positive bacteria other than Helicobacter pylori in human gastric juice and mucosa. Am J Gastroenterol (2006) 0.89
Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling. PLoS One (2010) 0.88
Predicting falls in people with multiple sclerosis: fall history is as accurate as more complex measures. Mult Scler Int (2013) 0.88
Complementary and alternative medicine in multiple sclerosis: survey of licensed naturopaths. J Altern Complement Med (2004) 0.87
Tumefactive multiple sclerosis and fingolimod: Immunotherapies and unintended consequences. Neurology (2013) 0.87
Prioritizing research needs based on a systematic evidence review: a pilot process for engaging stakeholders. Health Expect (2011) 0.87
Apical ballooning resulting from limbic encephalitis. Am J Med (2009) 0.87
Nicotine effects on alertness and spatial attention in non-smokers. Nicotine Tob Res (2002) 0.87
Novel method for measurement of fatigue in multiple sclerosis: Real-Time Digital Fatigue Score. J Rehabil Res Dev (2010) 0.87
Survival and reoperation rates after meniscal allograft transplantation: analysis of failures for 172 consecutive transplants at a minimum 2-year follow-up. Am J Sports Med (2014) 0.87
Mitochondrial calcium and its regulation in neurodegeneration induced by oxidative stress. Eur J Neurosci (2011) 0.87
The effects of omega-3 Fatty acids on matrix metalloproteinase-9 production and cell migration in human immune cells: implications for multiple sclerosis. Autoimmune Dis (2011) 0.86
Association between documented family history of cancer and screening for breast and colorectal cancer. Prev Med (2013) 0.86
Psychometric validation of the italian translation of the gastrointestinal symptom-rating scale and quality of life in reflux and dyspepsia questionnaire in patients with gastro-oesophageal reflux disease. Clin Drug Investig (2004) 0.86
The naturopathic medical research agenda: the future and foundation of naturopathic medical science. J Altern Complement Med (2006) 0.86
Binaural beat technology in humans: a pilot study to assess neuropsychologic, physiologic, and electroencephalographic effects. J Altern Complement Med (2007) 0.85
Sensitivity to mental effort and test-retest reliability of heart rate variability measures in healthy seniors. Clin Neurophysiol (2011) 0.85
Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome. BMC Nephrol (2007) 0.84
Ginkgo biloba does not improve cognitive function in MS: a randomized placebo-controlled trial. Neurology (2012) 0.84
Potential utility of near-infrared spectroscopy in out-of-hospital cardiac arrest: an illustrative case series. Prehosp Emerg Care (2012) 0.84
Adjunctive naturopathic care for type 2 diabetes: patient-reported and clinical outcomes after one year. BMC Complement Altern Med (2012) 0.84
Salivary cortisol lower in posttraumatic stress disorder. J Trauma Stress (2013) 0.83
Binaural beat technology in humans: a pilot study to assess psychologic and physiologic effects. J Altern Complement Med (2007) 0.83
Neuroregenerative and neuroprotective actions of neuroimmunophilin compounds in traumatic and inflammatory neuropathies. Neurol Res (2004) 0.83
Mitochondrial dysfunction and neurodegeneration in multiple sclerosis. Front Physiol (2013) 0.83
Complementary and alternative medicine: is there a role in multiple sclerosis? Curr Neurol Neurosci Rep (2006) 0.83
People with multiple sclerosis use many fall prevention strategies but still fall frequently. Arch Phys Med Rehabil (2013) 0.83
Peak high-frequency HRV and peak alpha frequency higher in PTSD. Appl Psychophysiol Biofeedback (2013) 0.82
Evaluation of failure to thrive: diagnostic yield of testing for renal tubular acidosis. Pediatrics (2003) 0.82
Internet-based Mindfulness Meditation for Cognition and Mood in Older Adults: A Pilot Study. Altern Ther Health Med (2016) 0.81